Azetidinone–retinoid hybrids: Synthesis and differentiative effects

As a part of a systematic investigation on the synthesis and biological activities of new β-lactam compounds, we examined β-lactam candidates 1, 2E and 2Z and their ability to induce cell proliferation or differentiation. Azetidinone 1 was chosen for its activity (previously evaluated) as selective...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of medicinal chemistry Vol. 70; pp. 857 - 863
Main Authors Pori, Matteo, Galletti, Paola, Soldati, Roberto, Calzà, Laura, Mangano, Chiara, Giacomini, Daria
Format Journal Article
LanguageEnglish
Published ISSY-LES-MOULINEAUX Elsevier Masson SAS 01.12.2013
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:As a part of a systematic investigation on the synthesis and biological activities of new β-lactam compounds, we examined β-lactam candidates 1, 2E and 2Z and their ability to induce cell proliferation or differentiation. Azetidinone 1 was chosen for its activity (previously evaluated) as selective HDAC8 inhibitor, whereas β-lactams 2E and 2Z were designed to have a hybrid retinoid-azetidinone structure, de novo synthesized and fully characterized. Biological activities were determined in cellular assays on neuroblastoma cells SH-SY5Y. Azetidinone 1, 2E and 2Z led to a moderate effect in decreasing SH-SY5Y cell proliferation and β-lactams 2E and 2Z induced an early stage differentiation. The present results uncovered a new role of specifically designed β-lactam compounds in epigenetic regulation. [Display omitted] •Synthesis of new β-lactam retinoid–azetidinone hybrids were reported.•Three azetidinone molecules were evaluated on neuroblastoma cells.•Differentiative effects were evaluated.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0223-5234
1768-3254
DOI:10.1016/j.ejmech.2013.09.057